drugset / Trial / NCT04756206
Role of Dutasteride in Treatment of Chronic Prostatitis
RandomizedParallel-groupTriple-blindTreatment
Summary
this placebo controlled study aims to evaluate the efficacy of Dutasteride in the management of Chronic prostatitis type 3.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2020-01-01
- Completion
- 2020-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dutasteride | Small molecule | 0.5 mg | — |